Evidence map›Paper›PMID 36301834›Full record

ArticlePloS one2022

Reproducibility and implementation of a rapid, community-based COVID-19 "test and respond" model in low-income, majority-Latino communities in Northern California.

Gabriel Chamie, Patric Prado, Yolanda Oviedo, Tatiana Vizcaíno, Carina Arechiga, Kara Marson, Omar Carrera, Manuel J Alvarado, Claudia G Corchado, Monica Gomez and 12 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Lessons from Two Latino Communities Working with Academic Partners to Increase Access to COVID-19 Testing.Progress in community health partnerships : research, education, and action · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 1 country.

Gabriel ChamieUniversity of California, San Francisco, San Francisco, California, United States of America.ORCID 0000-0002-5860-8081
Patric PradoUniversity of California, San Francisco, San Francisco, California, United States of America.
Yolanda OviedoCanal Alliance, San Rafael, California, United States of America.
Tatiana VizcaínoUnited Way-Merced, Merced, California, United States of America.
Carina ArechigaUniversity of California, San Francisco, San Francisco, California, United States of America.
Kara MarsonUniversity of California, San Francisco, San Francisco, California, United States of America.ORCID 0000-0001-9534-0371
Omar CarreraCanal Alliance, San Rafael, California, United States of America.
Manuel J AlvaradoUnited Way-Merced, Merced, California, United States of America.
Claudia G CorchadoUnited Way-Merced, Merced, California, United States of America.
Monica GomezUnited Way-Merced, Merced, California, United States of America.
Marilyn MochelUnited Way-Merced, Merced, California, United States of America.
Irene de LeonCanal Alliance, San Rafael, California, United States of America.
Kesia K GaribayUniversity of California, Merced, Merced, California, United States of America.
Arturo DurazoUniversity of California, Merced, Merced, California, United States of America.
Maria-Elena De Trinidad YoungUniversity of California, Merced, Merced, California, United States of America.
Irene H YenUniversity of California, Merced, Merced, California, United States of America.
John SaucedaUniversity of California, San Francisco, San Francisco, California, United States of America.ORCID 0000-0003-1975-3080
Susana RojasLatino Task Force for COVID-19, San Francisco, California, United States of America.
Joe DeRisiUniversity of California, San Francisco, San Francisco, California, United States of America.
Maya PetersenUniversity of California, Berkeley, Berkeley, California, United States of America.ORCID 0000-0002-5505-153X
Diane V HavlirUniversity of California, San Francisco, San Francisco, California, United States of America.
Carina MarquezUniversity of California, San Francisco, San Francisco, California, United States of America.
University of California, San Francisco · USMerced College · USUniversity of California, Merced · USUniversity of California, Berkeley · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 2001 to 2026
$57.4M
NIAID NIH HHS P30 AI027763NIMH NIH HHS P30 MH062246
6 · The paper itself

Abstract

objectiveTo evaluate implementation of a community-engaged approach to scale up COVID-19 mass testing in low-income, majority-Latino communities.

methodsIn January 2021, we formed a community-academic "Latino COVID-19 Collaborative" with residents, leaders, and community-based organizations (CBOs) from majority-Latinx, low-income communities in three California counties (Marin/Merced/San Francisco). The collaborative met monthly to discuss barriers/facilitators for COVID-19 testing, and plan mass testing events informed by San Francisco's Unidos en Salud "test and respond" model, offering community-based COVID-19 testing and post-test support in two US-census tracts: Canal (Marin) and Planada (Merced). We evaluated implementation using the RE-AIM framework. To further assess testing barriers, we surveyed a random sample of residents who did not attend the events.

resultsFifty-five residents and CBO staff participated in the Latino collaborative. Leading facilitators identified to increase testing were extended hours of community-based testing and financial support during isolation. In March-April 2021, 1,217 people attended mass-testing events over 13 days: COVID-19 positivity was 3% and 1% in Canal and Planada, respectively. The RE-AIM evaluation found: census tract testing coverage of 4.2% and 6.3%, respectively; 90% of event attendees were Latino, 89% had household income <$50,000/year, and 44% first-time testers (reach), effectiveness in diagnosing symptomatic cases early (median isolation time: 7 days) and asymptomatic COVID-19 (41% at diagnosis), high adoption by CBOs in both counties, implementation of rapid testing (median: 17.5 minutes) and disclosure, and post-event maintenance of community-based testing. Among 265 non-attendees surveyed, 114 (43%) reported they were aware of the event: reasons for non-attendance among the 114 were insufficient time (32%), inability to leave work (24%), and perceptions that testing was unnecessary post-vaccination (24%) or when asymptomatic (25%).

conclusionCommunity-engaged mass "test and respond" events offer a reproducible approach to rapidly increase COVID-19 testing access in low-income, Latinx communities.

Indexed as

COVID-19Community ParticipationCOVID-19 TestingHispanic or LatinoHumansReproducibility of ResultsSan FranciscoStakeholder Participation

Identifiers

PMID36301834
PMCPMC9612491
OpenAlexW4307441973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.